357 related articles for article (PubMed ID: 22075541)
1. Proton pump inhibitors versus histamine-2-receptor antagonists for the management of iatrogenic gastric ulcer after endoscopic mucosal resection or endoscopic submucosal dissection: a meta-analysis of randomized trials.
Yang Z; Wu Q; Liu Z; Wu K; Fan D
Digestion; 2011; 84(4):315-20. PubMed ID: 22075541
[TBL] [Abstract][Full Text] [Related]
2. Prospective randomized controlled trial to compare the effects of omeprazole and famotidine in preventing delayed bleeding and promoting ulcer healing after endoscopic submucosal dissection.
Tomita T; Kim Y; Yamasaki T; Okugawa T; Kondo T; Toyoshima F; Sakurai J; Tanaka J; Morita T; Oshima T; Fukui H; Hori K; Watari J; Matsumoto T; Miwa H
J Gastroenterol Hepatol; 2012 Sep; 27(9):1441-6. PubMed ID: 22497427
[TBL] [Abstract][Full Text] [Related]
3. Omeprazole may be superior to famotidine in the management of iatrogenic ulcer after endoscopic mucosal resection: a prospective randomized controlled trial.
Ye BD; Cheon JH; Choi KD; Kim SG; Kim JS; Jung HC; Song IS
Aliment Pharmacol Ther; 2006 Sep; 24(5):837-43. PubMed ID: 16918888
[TBL] [Abstract][Full Text] [Related]
4. Comparison of an ecabet sodium and proton pump inhibitor (PPI) combination therapy with PPI alone in the treatment of endoscopic submucosal dissection (ESD)--induced ulcers in early gastric cancer: prospective randomized study.
Asakuma Y; Kudo M; Matsui S; Okada M; Kawasaki M; Umehara Y; Ichikawa T; Kitai S
Hepatogastroenterology; 2009; 56(94-95):1270-3. PubMed ID: 19950775
[TBL] [Abstract][Full Text] [Related]
5. Proton pump inhibitor dose-related healing rate of artificial ulcers after endoscopic submucosal dissection: a prospective randomized controlled trial.
Kawano S; Okada H; Kawahara Y; Hori K; Tanioka D; Tsuzuki T; Inoue M; Yagi S; Takenaka R; Yamamoto K
Digestion; 2011; 84(1):46-53. PubMed ID: 21304241
[TBL] [Abstract][Full Text] [Related]
6. Role of antisecretory agents for gastric endoscopic submucosal dissection.
Fujishiro M; Chiu PW; Wang HP
Dig Endosc; 2013 Mar; 25 Suppl 1():86-93. PubMed ID: 23368844
[TBL] [Abstract][Full Text] [Related]
7. Effect of a proton pump inhibitor or an H2-receptor antagonist on prevention of bleeding from ulcer after endoscopic submucosal dissection of early gastric cancer: a prospective randomized controlled trial.
Uedo N; Takeuchi Y; Yamada T; Ishihara R; Ogiyama H; Yamamoto S; Kato M; Tatsumi K; Masuda E; Tamai C; Yamamoto S; Higashino K; Iishi H; Tatsuta M
Am J Gastroenterol; 2007 Aug; 102(8):1610-6. PubMed ID: 17403076
[TBL] [Abstract][Full Text] [Related]
8. Effects of administration of a proton pump inhibitor before endoscopic submucosal dissection for differentiated early gastric cancer with ulcer.
Myung YS; Hong SJ; Han JP; Park KW; Ko BM; Lee MS
Gastric Cancer; 2017 Jan; 20(1):200-206. PubMed ID: 26661593
[TBL] [Abstract][Full Text] [Related]
9. Can rebamipide and proton pump inhibitor combination therapy promote the healing of endoscopic submucosal dissection-induced ulcers? A randomized, prospective, multicenter study.
Shin WG; Kim SJ; Choi MH; Kim KO; Jang HJ; Park CH; Baek IH; Kim KH; Baik GH; Kae SH; Kim JH; Kim HY
Gastrointest Endosc; 2012 Apr; 75(4):739-47. PubMed ID: 22281110
[TBL] [Abstract][Full Text] [Related]
10. Prospective single-arm trial of two-week rabeprazole treatment for ulcer healing after gastric endoscopic submucosal dissection.
Niimi K; Fujishiro M; Goto O; Kodashima S; Minatsuki C; Hirayama I; Mochizuki S; Ono S; Yamamichi N; Kakushima N; Ichinose M; Koike K
Dig Endosc; 2012 Mar; 24(2):110-6. PubMed ID: 22348835
[TBL] [Abstract][Full Text] [Related]
11. A prospective randomized trial of either famotidine or omeprazole for the prevention of bleeding after endoscopic mucosal resection and the healing of endoscopic mucosal resection-induced ulceration.
Yamaguchi Y; Katsumi N; Tauchi M; Toki M; Nakamura K; Aoki K; Morita Y; Miura M; Morozumi K; Ishida H; Takahashi S
Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():111-5. PubMed ID: 15943857
[TBL] [Abstract][Full Text] [Related]
12. Role of mucoprotective agents in endoscopic submucosal dissection-derived ulcers: A systematic review.
Pittayanon R; Martel M; Barkun A
J Gastroenterol Hepatol; 2018 Dec; 33(12):1948-1955. PubMed ID: 29870582
[TBL] [Abstract][Full Text] [Related]
13. Treatment with proton pump inhibitors in acute non-variceal upper gastrointestinal bleeding: a meta-analysis.
Khuroo MS; Khuroo MS; Farahat KL; Kagevi IE
J Gastroenterol Hepatol; 2005 Jan; 20(1):11-25. PubMed ID: 15610441
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of endoscopic submucosal dissection versus endoscopic mucosal resection for tumors of the gastrointestinal tract.
Cao Y; Liao C; Tan A; Gao Y; Mo Z; Gao F
Endoscopy; 2009 Sep; 41(9):751-7. PubMed ID: 19693750
[TBL] [Abstract][Full Text] [Related]
15. Effect of lansoprazole versus roxatidine on prevention of bleeding and promotion of ulcer healing after endoscopic submucosal dissection for superficial gastric neoplasia.
Imaeda H; Hosoe N; Suzuki H; Saito Y; Ida Y; Nakamura R; Iwao Y; Ogata H; Hibi T
J Gastroenterol; 2011 Nov; 46(11):1267-72. PubMed ID: 21805066
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for bleeding after gastric endoscopic submucosal dissection: a systematic review and meta-analysis.
Libânio D; Costa MN; Pimentel-Nunes P; Dinis-Ribeiro M
Gastrointest Endosc; 2016 Oct; 84(4):572-86. PubMed ID: 27345132
[TBL] [Abstract][Full Text] [Related]
17. Effective healing of endoscopic submucosal dissection-induced ulcers by a single week of proton pump inhibitor treatment: a retrospective study.
Kajiura S; Hosokawa A; Ueda A; Mihara H; Ando T; Fujinami H; Nishikawa J; Ogawa K; Minemura M; Sugiyama T
BMC Res Notes; 2015 Apr; 8():150. PubMed ID: 25889379
[TBL] [Abstract][Full Text] [Related]
18. Rebamipide plus proton pump inhibitor versus proton pump inhibitor alone in the treatment of endoscopic submucosal dissection-induced gastric ulcer: a meta-analysis of randomized controlled trials.
Xiong J; Lai S; Zhang P; Li Q; Wei Y; Yang Y; Wang T; Liu L; Ma X; Chen D
Medicine (Baltimore); 2014 Sep; 93(12):e64. PubMed ID: 25211045
[TBL] [Abstract][Full Text] [Related]
19. The efficacy and safety of proton pump inhibitors vs histamine-2 receptor antagonists for stress ulcer bleeding prophylaxis among critical care patients: a meta-analysis.
Lin PC; Chang CH; Hsu PI; Tseng PL; Huang YB
Crit Care Med; 2010 Apr; 38(4):1197-205. PubMed ID: 20173630
[TBL] [Abstract][Full Text] [Related]
20. Effect of administration of a proton pump inhibitor for ulcerative differentiated early gastric cancer prior to endoscopic submucosal dissection.
Wang J; Shan F; Li S; Li Z; Wu Q
Dig Endosc; 2021 Sep; 33(6):939-947. PubMed ID: 33184984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
